Combination Antibiotic Therapy for Staphylococcus Aureus Bacteremia (NCT07376889)
COMBAT-SAB: Combination Antibiotic Therapy for Staphylococcus Aureus Bacteremia
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to see if, in selected patients with a serious bacterial infection of the bloodstream, treating the bacterial infection with a combination of antibiotics is more effective than treating the infection with a single antibiotic. Participants must have blood cultures which are positive for a certain type of bacteria.
Who can join: Review the eligibility criteria below.
Location: Platte Valley Hospital — Brighton, Colorado
Age range: 18 Years
🧪 Interventions in This Study
- Antibiotic Monotherapy (AM) for patients with methicillin-sensitive S. aureus bacteremia (MSSAB) (DRUG)
- Antibiotic Monotherapy (AM) for patients with methicillin-resistant S. aureus bacteremia (MRSAB) (DRUG)
- Combination Antibiotic Therapy (CAT) for patients with methicillin-sensitive S. aureus bacteremia (MSSAB) (DRUG)
- Combination Antibiotic Therapy (CAT) for patients with methicillin-resistant S. aureus bacteremia (MRSAB) (DRUG)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (13 Sites)
- Platte Valley Hospital — Brighton, Colorado
- Saint Joseph Hospital — Denver, Colorado
- St. Mary's Regional Hospital — Grand Junction, Colorado
- Good Samaritan Hospital — Lafayette, Colorado
- Lutheran Medical Center — Wheat Ridge, Colorado
- St. Vincent Regional Hospital — Billings, Montana
- St. James Hospital — Butte, Montana
- Holy Rosary Hospital — Miles City, Montana
- Intermountain Medical Center — Murray, Utah
- McKay-Dee Hospital — Ogden, Utah
- Utah Valley Hospital — Provo, Utah
- LDS Hospital — Salt Lake City, Utah
- St. George Regional Hospital — St. George, Utah
📞 Contact the Study Coordinator
Phone: (801) 507-7781
Email: Brandon.Webb@imail.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Staphylococcus Aureus Bacteremia
- Adjunctive Fosfomycin for Treatment of Staphylococcus Aureus Bacteraemia — Melbourne, Victoria
- Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia — Calgary, Alberta
- Staphylococcus Aureus Network Adaptive Platform Trial — Houston, Texas
- Evaluating Simplified Layered Consent for Clinical Trials — Calgary, Alberta
Explore by condition: All Staphylococcus Aureus Bacteremia clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.